Series A - iQure Pharma
Investment Firm
Overview
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Announced Date
Aug 31, 2022
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
2
| Investor Name |
|---|
 Keiretsu Forum Mid Atlantic |
 Keiretsu Forum Northwest |
Round Details and Background
iQure Pharma raised $600000 on 2022-08-31 in Series A
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 14, 2020 |  Convertible Note - iQure Pharma | 1 | - | 100.0K |
| May 25, 2020 | Convertible Note - iQure Pharma | - | 50.0K | |
| Oct 11, 2023 | Venture Round - iQure Pharma | 2 | - | 1.2M |
| Apr 05, 2024 | Debt Financing - iQure Pharma | - | 220.0K |
Recent Activity
There is no recent news or activity for this profile.